We are pleased to announce the support of the Lifeboat Foundation in working with us to promote healthy human longevity.
The Lifeboat Foundation is a nonprofit organization devoted to encouraging the promotion and advancement of science while helping develop strategies to survive existential risks and the possible abuse of technology. They are interested in biotechnology, nanotechnology, robotics and AI and fostering the safe and responsible use of these powerful new technologies. The Life Preserver program is aligned with our mission to promote and develop rejuvenation biotechnology capable of combating age-related diseases.
We believe that a bright future awaits mankind and support the ethical and safe use of new medical technologies being developed today, thus we consider the goals of the Lifeboat Foundation to be compatible with ours in regards to the extension of healthy lifespan and are pleased to collaborate with them to support this goal. As part of our commitment to the ethical progress of medical science LEAF promotes scientific research and learning via our crowdfunding website Lifespan.io and our educational hub at the LEAF website. A number of LEAF board members are already on the Scientific Advisory board for the Lifeboat Foundation and we look forward to working with them in the coming year.
With the first rejuvenation biotechnologies now arriving, such as Unity Biotechnology senolytic therapies that directly address one of the causes of aging entering human clinical trials soon, it is a very exciting time for medical science.
2016 saw Ichor Therapeutics successfully funding and moving towards testing a therapy based on SENS Research Foundation technology for the clearance of age-related metabolic waste into a treatment for Age-related Macular Degeneration. This could pave the way for more intense therapies for removing Lipofuscin from cells – an insoluble waste product that builds up in cells over time and ultimately destroys them – one of the causes of cell dysfunction with aging.
We recently enjoyed the successful first results of the MitoSENS mitochondrial repair project from SENS Research Foundation and a publication in the prestigious Oxford Journals. This was a great step forward as it confirmed the plausibility of repairing mitochondrial damage and what SENS Research has been proposing for over a decade. Hopefully now the first steps have been demonstrated we will see the end of opposition and the start of greater support for their work. LEAF is proud to have been involved in fundraising for the MitoSENS campaign and seeing these results made us very happy indeed.
LEAF also helped raise funds for ALT Cancer treatment research in 2016 in conjunction with the SENS Research Foundation as part of their OncoSENS campaign last year, which raised $72,000 for fundamental research into the ALT Cancer mechanism.
These are just a few examples of how science is on the cusp of a new age of medicine and a shift in how we perceive and treat age-related diseases. Joining forces with those who share a vision is critical in helping speed up progress and bringing safe and ethical therapies to all.